Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Targetnews2024-12-02T01:11:12+00:00December 2nd, 2024|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Can America’s Health Survive Robert F. Kennedy Jr.?news2024-11-16T02:51:41+00:00November 16th, 2024|The New York Times|
What Democrats Should Learn From Their Lossnews2024-11-13T16:49:52+00:00November 13th, 2024|The New York Times|
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?news2024-11-13T10:01:57+00:00November 13th, 2024|The New York Times|
Robert F. Kennedy Jr. se prepara para ejercer el poder en salud públicanews2024-11-07T08:05:06+00:00November 7th, 2024|The New York Times|
Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Powernews2024-11-06T22:09:44+00:00November 6th, 2024|The New York Times|
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
